Liu, Tingting
Zuo, Hongzhou
Ma, Di
Song, Dan
Zhao, Yuying
Cheng, Oumei
Funding for this research was provided by:
National Natural Science Foundation of China (81871002, 81471334, 81100981)
National Key Clinical Specialties Construction Program of China
Article History
Received: 23 April 2023
Accepted: 27 June 2023
First Online: 20 July 2023
Declarations
:
: The studies involving human participants were reviewed and approved by Parkinson’s Progression Markers Initiative. The patients and participants provided their written informed consent to participate in this study.
: Not applicable.
: The authors declare that they have no competing interests.